$MED
MEDIFAST INC

2020 Q4 Form 10-Q Financial Statement

#000155837020012437 Filed on November 03, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $264.9M $271.5M $190.1M
YoY Change 55.25% 42.83% 36.5%
Cost Of Revenue $65.70M $67.43M $47.13M
YoY Change 54.23% 43.09% 47.1%
Gross Profit $199.2M $204.0M $142.9M
YoY Change 55.57% 42.75% 33.33%
Gross Profit Margin 75.21% 75.16% 75.2%
Selling, General & Admin $160.4M $159.5M $122.7M
YoY Change 47.83% 30.0% 36.71%
% of Gross Profit 80.51% 78.16% 85.82%
Research & Development $900.0K $800.0K $600.0K
YoY Change 0.0% 33.33%
% of Gross Profit 0.45% 0.39% 0.42%
Depreciation & Amortization $2.000M $1.800M $1.200M
YoY Change 66.67% 50.0% 50.0%
% of Gross Profit 1.0% 0.88% 0.84%
Operating Expenses $161.2M $159.5M $122.7M
YoY Change 47.48% 30.0% 36.71%
Operating Profit $38.04M $44.56M $20.26M
YoY Change 102.68% 119.91% 16.0%
Interest Expense $0.00 $44.00K $324.0K
YoY Change -100.0% -86.42% -10.25%
% of Operating Profit 0.0% 0.1% 1.6%
Other Income/Expense, Net -$200.0K $74.00K $321.0K
YoY Change -76.95% -11.08%
Pretax Income $37.85M $44.63M $20.58M
YoY Change 99.41% 116.84% 15.45%
Income Tax $9.900M $10.18M $4.681M
% Of Pretax Income 26.16% 22.81% 22.74%
Net Earnings $27.99M $34.45M $15.90M
YoY Change 40.81% 116.66% 15.39%
Net Earnings / Revenue 10.57% 12.69% 8.37%
Basic Earnings Per Share $2.38 $2.93 $1.36
Diluted Earnings Per Share $2.36 $2.91 $1.32
COMMON SHARES
Basic Shares Outstanding 11.77M 11.77M 11.73M
Diluted Shares Outstanding 11.86M 12.07M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $338.2M $326.4M $178.1M
YoY Change 99.35% 83.26% -4.0%
Cash & Equivalents $163.7M $156.5M $81.20M
Short-Term Investments $174.5M $169.9M $96.91M
Other Short-Term Assets $5.900M $5.200M $4.800M
YoY Change -3.28% 8.33% 23.08%
Inventory $53.39M $41.74M $51.93M
Prepaid Expenses
Receivables $584.0K $647.0K $1.451M
Other Receivables $0.00 $0.00 $3.200M
Total Short-Term Assets $234.3M $217.5M $158.3M
YoY Change 52.0% 37.37% 4.2%
LONG-TERM ASSETS
Property, Plant & Equipment $27.63M $26.83M $26.25M
YoY Change 6.12% 2.21% 39.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.937M $3.002M $453.0K
YoY Change 732.01% 562.69% -67.64%
Total Long-Term Assets $41.77M $43.33M $40.28M
YoY Change 3.13% 7.57% 78.91%
TOTAL ASSETS
Total Short-Term Assets $234.3M $217.5M $158.3M
Total Long-Term Assets $41.77M $43.33M $40.28M
Total Assets $276.1M $260.8M $198.6M
YoY Change 41.83% 31.32% 13.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $107.7M $108.7M $75.00M
YoY Change 41.34% 44.93% 19.43%
Accrued Expenses $3.700M $3.300M $2.500M
YoY Change 15.63% 32.0%
Deferred Revenue $7.606M
YoY Change 75.54%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $111.4M $112.0M $77.52M
YoY Change 40.26% 44.46% 23.43%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.500M $8.800M $9.900M
YoY Change -27.88% -11.11%
Total Long-Term Liabilities $7.500M $8.800M $9.900M
YoY Change -27.88% -11.11%
TOTAL LIABILITIES
Total Short-Term Liabilities $111.4M $112.0M $77.52M
Total Long-Term Liabilities $7.500M $8.800M $9.900M
Total Liabilities $118.8M $120.8M $87.39M
YoY Change 32.31% 38.21% 39.14%
SHAREHOLDERS EQUITY
Retained Earnings $154.4M $139.8M $162.9M
YoY Change -8.55% -14.2% 30.74%
Common Stock $12.00K $12.00K $12.00K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $157.2M $140.0M $111.2M
YoY Change
Total Liabilities & Shareholders Equity $276.1M $260.8M $198.6M
YoY Change 41.83% 31.32% 13.84%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $27.99M $34.45M $15.90M
YoY Change 40.81% 116.66% 15.39%
Depreciation, Depletion And Amortization $2.000M $1.800M $1.200M
YoY Change 66.67% 50.0% 50.0%
Cash From Operating Activities $19.80M $41.10M $17.90M
YoY Change 3.12% 129.61% 155.71%
INVESTING ACTIVITIES
Capital Expenditures -$2.000M -$3.300M -$2.200M
YoY Change 122.22% 50.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities $2.600M $1.000M $1.300M
YoY Change -23.08% 30.0%
Cash From Investing Activities $600.0K -$2.300M -$1.000M
YoY Change -175.0% 130.0% 900.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.10M -13.20M -32.10M
YoY Change -41.78% -58.88% 473.21%
NET CHANGE
Cash From Operating Activities 19.80M 41.10M 17.90M
Cash From Investing Activities 600.0K -2.300M -1.000M
Cash From Financing Activities -13.10M -13.20M -32.10M
Net Change In Cash 7.300M 25.60M -15.20M
YoY Change -278.05% -268.42% -1269.23%
FREE CASH FLOW
Cash From Operating Activities $19.80M $41.10M $17.90M
Capital Expenditures -$2.000M -$3.300M -$2.200M
Free Cash Flow $21.80M $44.40M $20.10M
YoY Change 8.46% 120.9% 148.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000910329
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31573
dei Entity Registrant Name
EntityRegistrantName
Medifast, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3714405
dei Entity Address Address Line1
EntityAddressAddressLine1
100 International Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Baltimore
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21202
dei City Area Code
CityAreaCode
410
dei Local Phone Number
LocalPhoneNumber
581-8042
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MED
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11769830
CY2020Q3 us-gaap Revenues
Revenues
271470000
CY2019Q3 us-gaap Revenues
Revenues
190061000
us-gaap Revenues
Revenues
669930000
us-gaap Revenues
Revenues
543040000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
67434000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
47128000
us-gaap Cost Of Revenue
CostOfRevenue
171354000
us-gaap Cost Of Revenue
CostOfRevenue
134250000
CY2020Q3 us-gaap Gross Profit
GrossProfit
204036000
CY2019Q3 us-gaap Gross Profit
GrossProfit
142933000
us-gaap Gross Profit
GrossProfit
498576000
us-gaap Gross Profit
GrossProfit
408790000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
159477000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
122671000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
402385000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
336458000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
44559000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
20262000
us-gaap Operating Income Loss
OperatingIncomeLoss
96191000
us-gaap Operating Income Loss
OperatingIncomeLoss
72332000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
44000
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
324000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
212000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1061000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
12000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
74000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
321000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
224000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1050000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
44633000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
20583000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
96415000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
73382000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10180000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4681000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21550000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15347000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34453000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15902000
us-gaap Net Income Loss
NetIncomeLoss
74865000
us-gaap Net Income Loss
NetIncomeLoss
58035000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.93
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.91
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.91
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.77
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11766000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11731000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11772000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11823000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11857000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12065000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11840000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12174000
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.13
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
3.39
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.25
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34453000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15902000
us-gaap Net Income Loss
NetIncomeLoss
74865000
us-gaap Net Income Loss
NetIncomeLoss
58035000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-3000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1000
CY2020Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1000
CY2019Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
18000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
75000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
246000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
217460000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
16000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
72000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
245000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34451000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15918000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
74937000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
58280000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156486000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76974000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
82000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
235000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
647000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1437000
CY2020Q3 us-gaap Inventory Net
InventoryNet
41736000
CY2019Q4 us-gaap Inventory Net
InventoryNet
48771000
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
13433000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
15704000
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
5169000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5158000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6096000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
154151000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26828000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26039000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
11458000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12803000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3002000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
353000
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2042000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1307000
CY2020Q3 us-gaap Assets
Assets
260790000
CY2019Q4 us-gaap Assets
Assets
194653000
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
108678000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
76220000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3307000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3168000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
111985000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
79388000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8791000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10433000
CY2020Q3 us-gaap Liabilities
Liabilities
120776000
CY2019Q4 us-gaap Liabilities
Liabilities
89821000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11817000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12272000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11768000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11764000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
12000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
12000
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5135000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
97000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
25000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
139770000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
168788000
CY2020Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
46000
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
489000
CY2020Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
5000000
CY2019Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
63993000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
140014000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
104832000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
260790000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
194653000
us-gaap Net Income Loss
NetIncomeLoss
74865000
us-gaap Net Income Loss
NetIncomeLoss
58035000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5259000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5097000
us-gaap Share Based Compensation
ShareBasedCompensation
4243000
us-gaap Share Based Compensation
ShareBasedCompensation
3415000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-28000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-17000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
508000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3209000
med Amortization Of Premium On Investment Securities
AmortizationOfPremiumOnInvestmentSecurities
263000
med Amortization Of Premium On Investment Securities
AmortizationOfPremiumOnInvestmentSecurities
355000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-735000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1093000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-282000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3649000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7035000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13037000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-5169000
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
3200000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-938000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
232000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2566000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-188000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
30078000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13818000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
125367000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
65109000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2000000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
3730000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3852000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9224000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1852000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76974000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81364000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156486000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81196000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
14135000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17333000
us-gaap Dividends Cash
DividendsCash
13715000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34453000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5494000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1424000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
279000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
532000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
289000
us-gaap Payments Of Dividends
PaymentsOfDividends
39892000
us-gaap Payments Of Dividends
PaymentsOfDividends
26658000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
33114000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-44000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-59782000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
79512000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-168000
us-gaap Dividends Cash
DividendsCash
8955000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
104832000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
18477000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
981000
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
487000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
45000
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
13099000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
110749000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
21935000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1136000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1250000
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
29000
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5000000
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
13354000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
116736000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
2126000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
174000
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
36000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
13437000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
140014000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
109106000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
20750000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
990000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
269000
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
256000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
127000
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8918000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
122068000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
21383000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1255000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
102000
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9998000
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8797000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
126023000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15902000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1170000
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
33000
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
16000
CY2019Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
23116000
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8762000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
111200000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Reclassification -</b><span style="white-space:pre-wrap;"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates</b> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</p>
CY2020Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2900000
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
100000
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
13702000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10880000
CY2020Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
2761000
CY2019Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
4109000
CY2020Q3 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
6031000
CY2019Q4 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
4421000
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20650000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
31314000
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1408000
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1953000
CY2020Q3 us-gaap Inventory Net
InventoryNet
41736000
CY2019Q4 us-gaap Inventory Net
InventoryNet
48771000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
34453000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
15902000
us-gaap Net Income Loss
NetIncomeLoss
74865000
us-gaap Net Income Loss
NetIncomeLoss
58035000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11766000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11731000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11772000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11823000
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
91000
CY2019Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
334000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
68000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
351000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11857000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12065000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11840000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12174000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.93
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.91
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.91
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.77
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1400000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
300000
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
0.0
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
0.0
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2100000
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1200000
us-gaap Share Based Compensation
ShareBasedCompensation
4200000
us-gaap Share Based Compensation
ShareBasedCompensation
3400000
CY2019Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
900000
CY2019Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
700000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2600000
us-gaap Operating Lease Expense
OperatingLeaseExpense
2100000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.035
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-4000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
101000
us-gaap Operating Lease Payments
OperatingLeasePayments
2778000
us-gaap Operating Lease Payments
OperatingLeasePayments
2121000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
887000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1490000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1052000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3991000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3397000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1851000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1234000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1452000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12977000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
879000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
12098000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
26000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
97000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
25000
CY2020Q3 us-gaap Marketable Securities
MarketableSecurities
169665000
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
111000
CY2020Q3 us-gaap Interest Receivable
InterestReceivable
143000
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
169919000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156486000
CY2020Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
13433000
CY2019Q4 us-gaap Marketable Securities
MarketableSecurities
92416000
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
36000
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
226000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
92678000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76974000
CY2019Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
15704000
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2019Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2020Q3 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0

Files In Submission

Name View Source Status
0001558370-20-012437-index-headers.html Edgar Link pending
0001558370-20-012437-index.html Edgar Link pending
0001558370-20-012437.txt Edgar Link pending
0001558370-20-012437-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
med-20200930.xsd Edgar Link pending
med-20200930x10q.htm Edgar Link pending
med-20200930x10q_htm.xml Edgar Link completed
med-20200930xex10d1.htm Edgar Link pending
med-20200930xex10d1001.jpg Edgar Link pending
med-20200930xex31d1.htm Edgar Link pending
med-20200930xex31d2.htm Edgar Link pending
med-20200930xex32d1.htm Edgar Link pending
med-20200930_cal.xml Edgar Link unprocessable
med-20200930_def.xml Edgar Link unprocessable
med-20200930_lab.xml Edgar Link unprocessable
med-20200930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending